|
1
|
Geller DS and Gorlick R: Osteosarcoma: A
review of diagnosis, management, and treatment strategies. Clin Adv
Hematol Oncol. 8:705–718. 2010.PubMed/NCBI
|
|
2
|
Messerschmitt PJ, Garcia RM, Abdul-Karim
FW, Greenfield EM and Getty PJ: Osteosarcoma. J Am Acad Orthop
Surg. 17:515–527. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mirabello L, Troisi RJ and Savage SA:
International osteosarcoma incidence patterns in children and
adolescents, middle ages and elderly persons. Int J Cancer.
125:229–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jaffe N: Osteosarcoma: Review of the past,
impact on the future. The American experience. Cancer Treat Res.
152:239–262. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Daw NC, Billups CA, Rodriguez-Galindo C,
McCarville MB, Rao BN, Cain AM, Jenkins JJ, Neel MD and Meyer WH:
Metastatic osteosarcoma. Cancer. 106:403–412. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kansara M and Thomas DM: Molecular
pathogenesis of osteosarcoma. DNA Cell Biol. 26:1–18. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hansen MF: Genetic and molecular aspects
of osteosarcoma. J Musculoskelet Neuronal Interact. 2:554–560.
2002.PubMed/NCBI
|
|
8
|
Reddy KB: MicroRNA (miRNA) in cancer.
Cancer Cell Int. 15:382015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
McManus MT: MicroRNAs and cancer. Semin
Cancer Biol. 13:253–258. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang G, Lu X and Yuan L: LncRNA: A link
between RNA and cancer. Biochim Biophys Acta. 1839:1097–1109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guo Y, Chen D, Su X, Chen J and Li Y: The
lncRNA ELF3-AS1 promotes bladder cancer progression by interaction
with Krüppel-like factor 8. Biochem Biophys Res Commun.
508:762–768. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hezova R, Kovarikova A, Srovnal J,
Zemanova M, Harustiak T, Ehrmann J, Hajduch M, Sachlova M, Svoboda
M and Slaby O: MiR-205 functions as a tumor suppressor in
adenocarcinoma and an oncogene in squamous cell carcinoma of
esophagus. Tumuor Biol. 37:8007–8018. 2016. View Article : Google Scholar
|
|
14
|
Li J, Hu K, Gong G, Zhu D, Wang Y, Liu H
and Wu X: Upregulation of MiR-205 transcriptionally suppresses
SMAD4 and PTEN and contributes to human ovarian cancer progression.
Sci Rep. 7:413302017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guan B, Li Q, Shen L, Rao Q, Wang Y, Zhu
Y, Zhou XJ and Li XH: MicroRNA-205 directly targets Krüppel-like
factor 12 and is involved in invasion and apoptosis in basal-like
breast carcinoma. Int J Oncol. 49:720–734. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Steffner RJ and Jang ES: Staging of bone
and soft-tissue sarcomas. J Am Acad Orthop Surg. 26:e269–e278.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim SH, Park YY, Cho SN, Margalit O, Wang
D and DuBois RN: Krüppel-like factor 12 promotes colorectal cancer
growth through early growth response protein 1. PLoS One.
11:e01598992016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liang WC, Fu WM, Wong CW, Wang Y, Wang WM,
Hu GX, Zhang L, Xiao LJ, Wan DC, Zhang JF and Waye MM: The lncRNA
H19 promotes epithelial to mesenchymal transition by functioning as
miRNA sponges in colorectal cancer. Oncotarget. 6:22513–22525.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liz J and Esteller M: lncRNAs and
microRNAs with a role in cancer development. Biochim Biophys Acta.
1859:169–176. 2016. View Article : Google Scholar : PubMed/NCBI
|
